These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 36398743
21. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas. Teixeira MF, Sabidó M, Leturiondo AL, de Oliveira Ferreira C, Torres KL, Benzaken AS. Virol J; 2018 Feb 17; 15(1):36. PubMed ID: 29454382 [Abstract] [Full Text] [Related]
22. Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis. Menon S, Wusiman A, Boily MC, Kariisa M, Mabeya H, Luchters S, Forland F, Rossi R, Callens S, Vanden Broeck D. PLoS One; 2016 Feb 17; 11(10):e0163965. PubMed ID: 27764092 [Abstract] [Full Text] [Related]
23. Prevalence and risk factors of human papilloma virus infection among women living with HIV, Egypt, a cross sectional study. Ashry M, Shawky S, Mounir Z, Fathy F, Elsayed H, Kamal W, Hassany M. BMC Public Health; 2024 Jul 09; 24(1):1821. PubMed ID: 38978047 [Abstract] [Full Text] [Related]
24. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control. Ndizeye Z, Vanden Broeck D, Lebelo RL, Bogers J, Benoy I, Van Geertruyden JP. PLoS One; 2019 Jul 09; 14(6):e0209303. PubMed ID: 31237894 [Abstract] [Full Text] [Related]
25. Detection of HPV DNA in vaginal samples self-collected by women living with HIV treated through the Brazilian public health system: Prevalence and analysis of risk factors. Silveira MFD, Buffarini R, Gaspar PC, Machado HM, Bazzo ML, Scherer A, Colusso ÁL, Travassos AGÁ, Arakaki-Sanchez D, Baia-da-Silva DC, Oliveira EC, Zago IR, Moura MA, Lacerda MVG, Martins SM, Reuter T, Pinto VM, Perini W, Pereira GFM, Miranda AE. Rev Soc Bras Med Trop; 2023 Jul 09; 56():e02772023. PubMed ID: 37820103 [Abstract] [Full Text] [Related]
26. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, Touré-Coulibaly K, Welffens-Ekra C, Dabis F, Orth G. Int J Cancer; 1998 May 18; 76(4):480-6. PubMed ID: 9590121 [Abstract] [Full Text] [Related]
28. Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). Luque AE, Hitti J, Mwachari C, Lane C, Messing S, Cohn SE, Adler D, Rose R, Coombs R. Int J Infect Dis; 2010 Sep 18; 14(9):e810-4. PubMed ID: 20655263 [Abstract] [Full Text] [Related]
29. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study. Wagner A, Skof AS, Sehouli J, Richter R, Henrich W, von Weizsäcker K, Siedentopf JP, Chekerov R, Kaufmann AM, Rohr I. Int J Gynecol Cancer; 2022 Jun 06; 32(6):716-723. PubMed ID: 35354606 [Abstract] [Full Text] [Related]
30. Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa. Kelly HA, Ngou J, Chikandiwa A, Sawadogo B, Gilham C, Omar T, Lompo O, Doutre S, Meda N, Weiss HA, Delany-Moretlwe S, Segondy M, Mayaud P, HARP Study Group. PLoS One; 2017 Jun 06; 12(3):e0174117. PubMed ID: 28333966 [Abstract] [Full Text] [Related]
31. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program. Rosário A, Sousa A, Marinho-Dias J, Medeiros R, Lobo C, Leça L, Coimbra N, Tavares F, Baldaque I, Martins G, Monteiro P, Henrique R, Sousa H. J Med Virol; 2023 Jan 06; 95(1):e28414. PubMed ID: 36541747 [Abstract] [Full Text] [Related]
32. Veteran Women Living With Human Immunodeficiency Virus Have Increased Risk of Human Papillomavirus (HPV)-Associated Genital Tract Cancers. Clark E, Chen L, Dong Y, Raychaudhury S, White D, Kramer JR, Chiao E. Clin Infect Dis; 2021 May 04; 72(9):e359-e366. PubMed ID: 32785700 [Abstract] [Full Text] [Related]
33. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya. Guthrie BL, Rositch AF, Cooper JA, Farquhar C, Bosire R, Choi R, Kiarie J, Smith JS. Sex Transm Infect; 2020 Sep 04; 96(6):457-463. PubMed ID: 31919275 [Abstract] [Full Text] [Related]
34. HPV Types in Cervical Precancer by HIV Status and Birth Region: A Population-Based Register Study. Carlander C, Lagheden C, Eklund C, Nordqvist Kleppe S, Dzabic M, Wagner P, Yilmaz A, Elfgren K, Sönnerborg A, Sparén P, Dillner J. Cancer Epidemiol Biomarkers Prev; 2020 Dec 04; 29(12):2662-2668. PubMed ID: 32967862 [Abstract] [Full Text] [Related]
35. Human papillomavirus genotype distribution by cytological status and associated risk factors in the general population of Congolese women living in urban and rural areas: Implications for cervical cancer prevention. Tsimba Lemba PC, Boumba LMA, Péré H, Nganga PC, Veyer D, Puech J, Mboumba Bouassa RS, Malanda-Kiminou P, Moukassa D, Bélec L. Infect Dis Now; 2023 Oct 04; 53(8):104762. PubMed ID: 37454761 [Abstract] [Full Text] [Related]
36. High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020. Boni SP, Tenet V, Horo A, Heideman DAM, Bleeker MCG, Tanon A, Mian B, Mohenou ID, Ekouevi DK, Gheit T, Didi-Kouko Coulibaly J, Tchounga BK, Adoubi I, Clifford GM, Jaquet A, on behalf The IeDEA West Africa Collaboration. Int J Cancer; 2024 Mar 15; 154(6):962-968. PubMed ID: 37942579 [Abstract] [Full Text] [Related]
37. Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening. Cenci M, Rossi F, Pisani T. In Vivo; 2023 Mar 15; 37(5):2161-2165. PubMed ID: 37652482 [Abstract] [Full Text] [Related]
38. Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana. Tawe L, MacDuffie E, Narasimhamurthy M, Wang Q, Gaseitsiwe S, Moyo S, Kasvosve I, Shin SS, Zetola NM, Paganotti GM, Grover S. Int J Cancer; 2020 Mar 15; 146(6):1667-1673. PubMed ID: 31325316 [Abstract] [Full Text] [Related]
39. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV. Kahesa C, Thomsen LT, Linde DS, Mchome B, Katanga J, Swai P, Manongi R, Kjaerem M, Iftner T, Waldstrøm M, Mwaiselage J, Rasch V, Kjaer SK. Int J Cancer; 2023 Feb 15; 152(4):686-696. PubMed ID: 36093587 [Abstract] [Full Text] [Related]
40. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IA, Odberg Pettersson K. Virol J; 2014 Jan 15; 11():5. PubMed ID: 24433568 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]